AI Article Synopsis

  • - The study aimed to evaluate the effectiveness of ginger-partitioned moxibustion in treating chemotherapy-induced leukopenia and improving patient quality of life.
  • - In a multi-center, randomized controlled trial involving 221 patients, the test group receiving moxibustion showed significantly higher cure and effectiveness rates compared to the control group receiving oral Chinese medicine (84.1% vs. 35.2%).
  • - The results suggest that ginger-partitioned moxibustion is a reliable and superior treatment option for managing leukopenia caused by chemotherapy, with improved clinical symptoms and no reported adverse effects.

Article Abstract

Objective: To prove the therapeutic effect of ginger-partitioned moxibustion on leukopenia induced by chemotherapy and effect on life quality of the patient with tumor after chemotherapy.

Methods: Randomized, controlled, multi-central cooperative method was used and the patients confirmed to the enrolled criteria were divided in-to two groups. The test group were treated with ginger-partitioned moxibustion at Dazhui (GV 14), Geshu (BL 17), Pishu (BL 20), etc.; and the control group with oral administration of Chinese patent medicine.

Results: Out of the 221 cases confirmed to program analysis, 113 cases were in the test group and 108 cases in the control group. After 10 days, the cured rate and the effective rate were 84.1% and 66.4% in the test group and 35.2% and 33.3% in the control group, respectively, with very significant differences between the two groups (both P < 0.01); fifteen days later, the therapeutic effects in the two groups were maintained. The two methods could improve clinical symptoms, with the test group being better than the control group. Any adverse response was not found in the two groups, and the injuries of functions of the heart, lung and kidney induced by chemotherapy had some improvement.

Conclusion: The therapeutic effect of ginger-partitioned moxibustion on luekopenia induced by chemotherapy is reliable and is better than oral administration of Chinese patent medicine, with a better duplication.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ginger-partitioned moxibustion
16
test group
16
control group
16
induced chemotherapy
12
leukopenia induced
8
therapeutic ginger-partitioned
8
group
8
oral administration
8
administration chinese
8
chinese patent
8

Similar Publications

Objectives: To observe the efficacy and safety of ginger-partitioned moxibustion combined with ringheaded thumb-tack needle stimulation in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in patients with malignant tumors.

Methods: Patients with malignant tumors and suffering from chemotherapy were randomly divided into control group (35 cases, 4 cases dropped off) and observation group (35 cases, 2 cases dropped off). The patients of the control group were treated by orally taking ondansetron hydrochloride tablets 8 mg/time, 3 times a day for 3 d, and those of the observation group treated by ginger-partitioned moxibustion combined with ringheaded thumb-tack needle stimulation of Zusanli(ST36), Neiguan(PC6), Tianshu(ST25), Zhongwan(CV12) and Guanyuan(CV4) once a day for a total of 3 d, based on the treatment of the control group.

View Article and Find Full Text PDF

Efficacy and Safety of Ginger on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Cancer Nurs

April 2024

Author Affiliations: School of Medicine, College of Medicine, Taipei Medical University (Drs Lin and S.-H. Huang); Cochrane Taiwan, Taipei Medical University (Drs Tam and T.-W. Huang); Division of General Surgery, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University (Dr Tam); Division of General Surgery, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, New Taipei City (Dr Tam); School of Nursing, College of Nursing, Taipei Medical University (Dr T.-W. Huang); and Department of Nursing and Research Center in Nursing Clinical Practice, Wan Fang Hospital, Taipei Medical University (Dr T.-W. Huang), Taipei, Taiwan; and Department of Nursing, Faculty of Medicine, Universitas Pendidikan Ganesha (Mr Gautama), Bali, Indonesia.

Background: Chemotherapy-induced nausea and vomiting (CINV) is a prevalent and distressing side effect. Historically, ginger has been explored as a potential remedy for various ailments, including its potential efficacy against CINV.

Objective: The aim of this study was to determine whether taking ginger supplements can relieve CINV.

View Article and Find Full Text PDF

Background: Diarrhea-predominant irritable bowel syndrome (IBS-D) is a functional gastrointestinal disorder that severely affects patients' life. Moxibustion is believed to be an effective way to treat IBS-D. However, the therapeutic effects and the underlying mechanisms in symptom management of IBS-D by different moxibustion therapies remain unclear.

View Article and Find Full Text PDF

Objective: To observe the effect of ginger-partitioned moxibustion on digestive tract reaction, quality of life and white blood cell count after chemotherapy in advanced malignant bone tumors patients.

Methods: A total of 64 patients were randomly divided into an observation group and a control group, 32 cases in each group. Both groups were treated with adriamycin combined with cisplatin (AP) chemotherapy.

View Article and Find Full Text PDF

Objective: To compare the therapeutic effect between long-snake moxibustion combined with western medication and simple medication on diarrhea type irritable bowel syndrome (IBS-D) of spleen and kidney deficiency.

Methods: A total of 60 patients with IBS-D of spleen and kidney deficiency were randomized into an observation group and a control group, 30 cases in each one. In the control group, loperamide hydrochloride capsule (2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!